CSIMarket


Integrated Biopharma Inc  (INBP)
Other Ticker:  
 

Integrated Biopharma Inc

INBP's Fundamental analysis






Integrated Biopharma Inc's sales fell by -15.96 % in I. Quarter 2021 from the same quarter a year ago. Ranking at No. 2887

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 23.1 %

Integrated Biopharma Inc's net profit deacreased by -50.43 % in I. Quarter 2021 year on year, to $1 millions.

More on INBP's Growth


Integrated Biopharma Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Integrated Biopharma Inc PEG ratio is at 0.07 , above Biotechnology & Pharmaceuticals industry PEG average of 0.
Company
4.42
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 0.57.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.12.


More on INBP's Valuation
 
 Total Debt (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 11.89
 Tangible Book Value (Per Share $) 0.46

Integrated Biopharma Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Integrated Biopharma Inc PEG ratio is at 0.07 , above Biotechnology & Pharmaceuticals industry PEG average of 0.
Company
4.42
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 0.57.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.12.

Integrated Biopharma Inc Price to Book Ratio is at 2.34 lower than Indusry Avg. of 1427.3. and higher than S&P 500 Avg. of -0

More on INBP's Valuation

  Market Capitalization (Millions $) 35
  Shares Outstanding (Millions) 33
  Employees -
  Revenues (TTM) (Millions $) 61
  Net Income (TTM) (Millions $) 7
  Cash Flow (TTM) (Millions $) -0
  Capital Exp. (TTM) (Millions $) -0
  Total Debt (Millions $) 0
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 11.89
  Tangible Book Value (Per Share $) 0.46

  Market Capitalization (Millions $) 35
  Shares Outstanding (Millions) 33
  Employees -
  Revenues (TTM) (Millions $) 61
  Net Income (TTM) (Millions $) 7
  Cash Flow (TTM) (Millions $) -0
  Capital Exp. (TTM) (Millions $) -0

INBP's Profitability Comparisons
Integrated Biopharma Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2021 to 4.59 % from 7.69 % in IV. Quarter.

Integrated Biopharma Inc net profit margin of 4.05 % is currently ranking no. 25 in Biotechnology & Pharmaceuticals industry, ranking no. 195 in Healthcare sector and number 2329 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 2.21
  Total Debt to Equity (MRQ) 0.01
  Tangible Leverage Ratio (MRQ) 0.63
  Asset Turnover Ratio (TTM) 2.42
  Inventory Turnover Ratio (TTM) 4.07



Integrated Biopharma Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2021 to 4.59 % from 7.69 % in IV. Quarter.

Integrated Biopharma Inc net profit margin of 4.05 % is currently ranking no. 25 in Biotechnology & Pharmaceuticals industry, ranking no. 195 in Healthcare sector and number 2329 in S&P 500.

More on INBP's Key Ratios





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ENFN's Profile

Stock Price

ENFN's Financials

Business Description

Fundamentals

Charts & Quotes

ENFN's News

Suppliers

ENFN's Competitors

Customers & Markets

Economic Indicators

ENFN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071